These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10471193)
1. Pneumococcal immunization and public health: the Canadian experience. Spika JS; Keresz D; Deeks S; Talbot JA Vaccine; 1999 Jul; 17 Suppl 1():S105-8. PubMed ID: 10471193 [TBL] [Abstract][Full Text] [Related]
2. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996. Fedson DS Clin Infect Dis; 1998 May; 26(5):1117-23. PubMed ID: 9597239 [TBL] [Abstract][Full Text] [Related]
3. The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007. Bettinger JA; Scheifele DW; Kellner JD; Halperin SA; Vaudry W; Law B; Tyrrell G; Vaccine; 2010 Feb; 28(9):2130-6. PubMed ID: 20044050 [TBL] [Abstract][Full Text] [Related]
4. Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study. LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Li L; Ambrose A; Hatchette TF; Lang AL; Gillis H; Martin I; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy A; McGeer A; Moraca S; Semret M; Stiver G; Trottier S; Valiquette L; Webster D; McNeil SA; Vaccine; 2017 Jun; 35(29):3647-3654. PubMed ID: 28554501 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. Robinson KA; Baughman W; Rothrock G; Barrett NL; Pass M; Lexau C; Damaske B; Stefonek K; Barnes B; Patterson J; Zell ER; Schuchat A; Whitney CG; JAMA; 2001 Apr; 285(13):1729-35. PubMed ID: 11277827 [TBL] [Abstract][Full Text] [Related]
6. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). Nuorti JP; Whitney CG; MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868 [TBL] [Abstract][Full Text] [Related]
7. Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure. Yang TU; Kim E; Park YJ; Kim D; Kwon YH; Shin JK; Park O Vaccine; 2016 Mar; 34(13):1623-1629. PubMed ID: 26850759 [TBL] [Abstract][Full Text] [Related]
8. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012. Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ; Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450 [TBL] [Abstract][Full Text] [Related]
9. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults. Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785 [TBL] [Abstract][Full Text] [Related]
10. Recurrent invasive pneumococcal disease in children--host factors and vaccination response. Ingels HA Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055 [TBL] [Abstract][Full Text] [Related]
11. Preventing pneumococcal disease: a Canadian consensus conference. 16-18 February 1998. Can Commun Dis Rep; 1999 Feb; 25(4):25-35. PubMed ID: 10079579 [No Abstract] [Full Text] [Related]
12. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland. Rinta-Kokko H; Palmu AA; Auranen K; Nuorti JP; Toropainen M; Siira L; Virtanen MJ; Nohynek H; Jokinen J Vaccine; 2018 Apr; 36(15):1934-1940. PubMed ID: 29526371 [TBL] [Abstract][Full Text] [Related]
13. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Advisory Committee on Immunization Practices MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835 [TBL] [Abstract][Full Text] [Related]
14. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature. Tsaban G; Ben-Shimol S Vaccine; 2017 May; 35(22):2882-2891. PubMed ID: 28449971 [TBL] [Abstract][Full Text] [Related]
15. Time for changes in pneumococcal vaccination of adults? Overman MC J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S19-22. PubMed ID: 22086890 [TBL] [Abstract][Full Text] [Related]
16. Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada. Feavers I; Knezevic I; Powell M; Griffiths E; Vaccine; 2009 Jun; 27(28):3681-8. PubMed ID: 19442421 [TBL] [Abstract][Full Text] [Related]